AR
Anish Rohitkumar Parikh
About Anish Rohitkumar Parikh
Data last updated:
Anish Rohitkumar Parikh is a Director at Mahed Pharma Limited (since 2024). The companies operate in Paper. Earlier, Anish Rohitkumar Parikh was a Director at Abdan Pharmacare Private Limited (from 2015).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Mahed Pharma Limited U21009GJ2024PLC148320 | Director | 05 Feb 2024 | 2024 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Abdan Pharmacare Private Limited U24230GJ2015PTC081889 | Director | 13 Jan 2015 | 2015 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Anish Rohitkumar Parikh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ektaben Anishkumar Parikh | 10492849 | Mahed Pharma Limited | Director |
| Sunilkumar Sudhirkumar Shah | 10492850 | Mahed Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anish Rohitkumar Parikh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anish Rohitkumar Parikh
Anish Rohitkumar Parikh currently holds 1 directorship: Mahed Pharma Limited (Director, since 05 Feb 2024).
Anish Rohitkumar Parikh was first appointed on 13 Jan 2015 as Director at Abdan Pharmacare Private Limited. The most recent appointment on record is 05 Feb 2024 at Mahed Pharma Limited.
Anish Rohitkumar Parikh held 1 earlier board appointment: Abdan Pharmacare Private Limited (Director, from 13 Jan 2015).
The current boards of Anish Rohitkumar Parikh's companies include Ektaben Anishkumar Parikh (Mahed Pharma Limited), Sunilkumar Sudhirkumar Shah (Mahed Pharma Limited).